Active ingredient
Cabozantinib
4 finished FDA listings contain Cabozantinib as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- CABOZANTINIB, CABOZANTINIB S-MALATE
- Dosage forms
- Capsule, Tablet
- Routes
- Oral
- Manufacturers / labelers
- 1
- Strengths listed
- 20 mg/1 · 40 mg/1 · 60 mg/1
- Brand names in FDA listings
- Cabometyx, Cometriq
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 1363268
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 203756 | EXELIXIS | 2012-11-29 | 1 |
| NDA 208692 | EXELIXIS INC | 2016-04-25 | 3 |
Official labeling on DailyMed
- COMETRIQ (CABOZANTINIB) KIT COMETRIQ (CABOZANTINIB) CAPSULE [EXELIXIS, INC.] · version 16 · 2025-11-17
- CABOMETYX (CABOZANTINIB) TABLET [EXELIXIS, INC.] · version 18 · 2025-11-17
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.